Keyword: Boehringer Ingelheim
News
05.01.2017
- French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have completed their business swap, which sees Sanofi take Boehringer’s consumer healthcare (CHC)...
News
05.12.2016
- German drugmaker Boehringer Ingelheim and China Southeast University Institute of Life Sciences have started a joint research project to develop new treatment approaches for...
News
07.10.2016
- German drugmaker Boehringer Ingelheim is selling the pet vaccines portfolio of its US subsidiary Vetmedica to Eli Lilly’s animal health subsidiary Elanco for $885 million to allay...
News
20.09.2016
- French drugmaker Sanofi has filed a patent infringement suit in the United States District Court for the District of Delaware charging US pharmaceutical producer Merck with...
News
29.06.2016
- Following six months of negotiations, French drugmaker Sanofi and German pharmaceutical company Boehringer Ingelheim have agreed an asset swap that sees Sanofi exchanging its...
News
16.06.2016
- Simone Menne has been appointed chief financial officer (CFO) of German drugmaker Boehringer Ingelheim with effect from Sept. 1, 2016. She will succeed Hubertus von Baumbach, who...
News
09.03.2016
- US drug maker AbbVie and Germany’s Boehringer Ingelheim are collaborating to develop and commercialize BI 655066, a potential treatment for psoriasis. The drug is also being...
News
03.03.2016
- Privately owned German drugmaker Boehringer Ingelheim is talking to AbbVie of the US about a partnership in oncology potentially worth billions of dollars, the news agency...
